Help us explore even more possibilities of T1D research by joining this year’s One Walk Step Challenge
The past 12 months has been challenging in so many ways, particularly for our community. However, as with every challenge the resilient T1D community has been faced with, the pandemic, and the challenges it brought with it, has certainly not defined us. During this time, we’ve continued to see an almost limitless amount of courage, strength, and resilience from all of you.
The challenges of the past 12 months and the impact COVID-19 has had on all our lives are both timely reminders of why we do what we do at JDRF. Thanks to your unconditional support, we haven’t let the pandemic pivot us away from our mission to improve lives and ultimately cure T1D.
In that spirit, I’m delighted to share that the One Walk Step Challenge is back in 2021. This is an exciting time of the year for all of us, and on the 100th anniversary of the discovery of insulin we’re setting an even more exciting target. We’ll be asking you to walk 100km to acknowledge 100 years since the discovery of insulin.
One Walk was designed to bring communities closer by allowing them to meet and walk together in person. Last year, due to the pandemic, we had to make a tough decision to take the event virtual. Taking an event as large as One Walk online came with a set of challenges, but we were privileged to feel the same support, excitement, and response from our community as we did at our flagship physical events. As a result, we raised an extraordinary $1.3 million together. We are so grateful for your support.
As we continue to live through the uncertainties of COVID-19, we have once again decided to make One Walk virtual for the health and safety of our community, and to maximise our support of vital T1D research. Nonetheless, our commitment to help you unite as a community online remains as strong as ever. We have a new set of challenges and targets to achieve with this year’s One Walk.
We look forward to inviting you to join the One Walk Step Challenge on August 1. Please register here for the exciting event beginning October 1. You can also follow our Facebook page or join our One Walk Step Challenge Facebook group to stay engaged and learn about our latest developments.
Thank you for your continued support.
Mike Wilson OAM,
Chief Executive Officer
JDRF welcomes TGA approval on Pfizer vaccine for children aged 12-15
JDRF Australia welcomes the announcement that the Therapeutic Goods Administration (TGA) has approved the Pfizer COVID-19 vaccine for children aged 12-15. We look forward to the final decision from the Australian Technical Advisory Group on Immunisation (ATAGI) to prioritise children with underlying conditions, including type 1 diabetes, and include them immediately in the vaccine rollout. […]
JDRF welcomes leading medical researcher to Board to support continued research excellence
JDRF Australia are delighted to welcome Professor Fabienne Mackay to the Board of JDRF Australia. Professor Mackay, who joined the Board at the June 2021 Board meeting, will also play an important role on JDRF’s Board Research Committee, evaluating and ensuring JDRF continues to support the best local research into type 1 diabetes (T1D). Prof. Mackay obtained her PhD from Louis Pasteur University in Strasbourg, France and has more than […]
New Science Accelerator Grants Awarded to Early-Mid Career Researchers
JDRF and The Leona M. and Harry B. Helmsley Charitable Trust are excited to announce more than $1.2 million in new funding for three outstanding early-mid career Australian researchers. The ENDIA Early-Mid Career Science Accelerator Awards will support the researchers in carrying out new projects using samples collected as part of the ENDIA study, the […]
T1D Research Roundup: June 2021
Our research roundups bring you the most exciting T1D research stories from around the world – the new advances in treatment, devices and knowledge that are making the biggest impact in the fight to cure, treat and prevent T1D. This month, the American Diabetes Association held their 81st Scientific Sessions. The world’s top type 1 […]